ConsumerComplaintBoard.org
  • Home
  • Categories
    • CONSTRUCTION DEFECTS
    • Automotive Defect
    • DEFECTIVE PRODUCTS
    • Employee Rights
    • Data Breach
  • Contact
  • Settlements

Herceptin Manufacturer Genentech Forcing Consumers to Overpurchase the Cancer Drug Class Action Investigation

Investigating a class action lawsuit on behalf of individuals and agencies using the drug Herceptin.  Genentech, the manufacturer of the cancer drug, appears to have misrepresented the amount of Herceptin contained in a single vial of the reconstituted solution.  Genentech instructs consumers to combine a 440mg vial of Herceptin with 20mL of dissolving liquid.  It then claims the resulting solution will contain 21 mg/mL of the cancer drug, when it will not.    As a result, patients are improperly dosed, and either paying for more Herceptin than intended, or paying full price, but receiving less than what is required.  If you use the drug Herceptin, or are a healthcare provider that treats patients with Herceptin, please contact us for a free consultation.


​

    LEARN MORE

Submit
Disclaimer

SUBSCRIBE TO NEWSLETTER

Stay Informed
​
with our Newsletter

SUBSCRIBE

​Automotive Defect
Construction Defect
Product Defects
Employee Rights
Medical Devices
​Dangerous Drugs​


​Personal Injury
Consumer Rights
Contract Rights
Whistleblower
​Investor Fraud
Antitrust
Tell us About a Case
​
Settlements 
​Contact Us
​©️ 2022 All Rights Reserved.
ConsumerComplaintBoard.org​
​​Disclaimer & Terms of Use

The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation.  Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted. ​
  • Home
  • Categories
    • CONSTRUCTION DEFECTS
    • Automotive Defect
    • DEFECTIVE PRODUCTS
    • Employee Rights
    • Data Breach
  • Contact
  • Settlements